News

NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Co., marking further progress toward establishing the first existing commercially viable domestic source of the radioisotope 99molybdenum (99Mo).

Home August 20, 2014
Home
Technology

GE Healthcare introduces the Vscan with Dual Probe with the first of its kind 2-in-1 probe to give healthcare providers more uses for pocket ultrasound.

Home August 20, 2014
Home
U.S. Department of Justice Close Investigation PLATO Clinical Trial Ticagrelor
Feature

AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial that tested the safety and effectiveness of the blood thinner ticagrelor (Brilinta).

Home August 20, 2014
Home
News

Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire.

Home August 20, 2014
Home
Technology

August 20, 2014 — Advanced Ultrasound Electronics announced the availability of Sono-Wipes, a one-step disinfectant deodorizer wipe specifically made for ultrasound equipment.

Home August 20, 2014
Home
Technology

August 20, 2014 — Vital Images Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Image Denoising software, a post-processing filter designed to be used in conjunction with original image data used with its Vitrea software.

Home August 20, 2014
Home
News

Cardiovascular Systems is recalling certain lots of the Diamondback 360 Peripheral Orbital Atherectomy System, because they may contain defective saline sheaths that could fracture during use. If this happens, fragments of the sheath could possibly block blood vessels. The U.S. Food and Drug Administration (FDA) said as of this week, there are no reports of patient injuries to date.

Home August 19, 2014
Home
Medical Record Software Medical Collaboration EMR PACS
Feature

Healthcare technology has evolved immensely in the past few years. With electronic medical records (EMR), medical image transfers or telemedicine, it is easy to forget that the priority is the patient — an individual person with unique needs, concerns and feelings.

Home August 19, 2014
Home
News

Bluegrass Vascular Technologies closed $4.5 million in Series A financing, that will allow the company to obtain CE mark for the Surfacer Inside-Out Access Catheter System.

Home August 19, 2014
Home
News

At the Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting Sept. 13-17, Toshiba will display newer features offered on its Infinix cardiovascular X-ray system to improve diagnostic accuracy and patient safety.

Home August 19, 2014
Home
News

August 18, 2014 — Two Mount Sinai research studies in the August issue of the Journal of the American College of Cardiology (ACC): Cardiovascular Imaging show the potential of using tele-robotic medicine when diagnosing heart failure patients.

Home August 18, 2014
Home
News

A clinical trial being conducted at Mission Health on a special catheter could one day help people with a persistent heart condition that does not respond to medication.

Home August 18, 2014
Home
News

Polidocanol injectable foam (Varithena), the only U.S. Food and Drug Administration (FDA)-approved foam for the treatment of incompetent great saphenous veins (GSV), accessory saphenous veins and visible varicosities of the GSV system both above and below the knee.

Home August 18, 2014
Home
HIPAA, HIPPA, cyber security concerns are rising over how to better securing patient records.
Feature | Cybersecurity | Yvonne Li

The healthcare industry is becoming more mobile and efficient than ever before thanks to the adoption of technologies such as electronic health records (EHR) and electronic sharing, storing and accessing of medical data. These advances have all helped to give patients a more dynamic and comprehensive healthcare experience. They have also helped empower patients to take control of their own healthcare history and information.

Home August 18, 2014
Home
News

OrbusNeich announced first patient enrollment in the Randomized Evaluation of short-term Dual anti platelet therapy in patients with acute coronary syndrome treated with the Combo Dual Therapy StEnt (REDUCE) Study.

Home August 15, 2014
Home
Subscribe Now